COVID-19 cases are rising globally, particularly in Asia with the JN.1 Omicron variant. The article discusses existing vaccine effectiveness against this variant. mRNA vaccines (Pfizer-BioNTech, Moderna) and vector vaccines (Johnson & Johnson, AstraZeneca) are mentioned. Updated vaccines may still offer protection against severe illness.
